Teva Says No Chairman Chosen After Investor Names Elstein
This article is for subscribers only.
Teva Pharmaceutical Industries Ltd. denied that it has chosen a new chairman after an activist investor identified Vice Chairman Amir Elstein as the board’s pick to oversee the generic-drug maker.
Moshe Many, Teva’s former vice chairman, informed investor Benny Landa that Elstein was chosen to replace outgoing chairman Phillip Frost, Landa wrote on his blog in a post dated yesterday. He confirmed the contents of the blog in a phone interview today.